Norsad Capital, an impact investor and private creditor provider, has structured a facility to help Ruai Family Hospital (RFH) improve access to affordable oncology healthcare for Nairobi residents.
The facility will enable Ruai Family Hospital to complete the construction of an oncology centre that will provide high-quality cancer diagnosis and treatment.
“The growing demand for affordable cancer diagnosis and treatment and the overflow of public hospitals, due to the lack of critical equipment, has prompted us to deliver this service to the Kenyan populace,” says Dr Maxwel Okoth, Founder and Group Managing Director at RFH.
Highlights
- Cancer ranks as the third highest cause of death and the second most prevalent noncommunicable disease in Kenya, with reported figures of 47,887 new cases in 2018 and 42,116 new cases in 2020.
- RFH, under the transaction advice of Noble Stride Capital, aims to address the growing demand for affordable cancer care and the overflow of public hospitals by building an oncology centre that will serve patients across Africa.
- Norsad Capital’s investment will support RFH’s mission of ensuring accessibility to the best medical practices and cutting-edge technological advancements, all delivered at affordable prices.